Collaborations & Alliances
Related Searches:
Filter by:
556 - 570 of 1091 results
August 12, 2010
NextWave Pharmaceuticals and Tris Pharma have entered a collaboration agreement under which Tris Pharma will use its drug delivery technology for liquid and solid formulations to enhance NextWave's CNS product portfolio.
Read More »
August 10, 2010
Sanofi-Aventis and Scripps Genomic Medicine (SGM) entered a strategic alliance to advance R&D initiatives in the field of personalized medicine.
Read More »
August 10, 2010
Scancell Holdings and Cancer Research Technology, Ltd. (CRT) have signed an agreement under which Scancell has been granted a license to use a human antibody known as 105AD7.
Read More »
August 5, 2010
CDMO will provide solutions for unique prostate cancer treatment.
Read More »
August 3, 2010
Seattle Genetics and Genentech have expanded their antibody-drug conjugate (ADC) collaboration.
Read More »
July 29, 2010
Aptuit, Inc. and Siena Biotech entered into a strategic partnership under which Siena Biotech will take a minority stake in Aptuit’s operations in Verona, Italy and Aptuit will serve as Siena’s provider of choice for its development pipeline.
Read More »
July 28, 2010
Astellas has extended its non-exclusive license agreement through 2023 to use Regeneron's VelocImmune technology for its research programs to discover fully human monoclonal antibody product candidates.
Read More »
July 23, 2010
Firms to collaborate on EU patient registries and real-world studies
Read More »
July 14, 2010
Pfizer and Samsung Medical Center (SMC) have formed a research partnership to jointly analyze tumors from Korean patients to generate gene expression profiles in an effort to direct therapies and enhance clinical outcomes in the patients with liver cancer
Read More »
July 14, 2010
Jonathan M Fishbein, M.D. has been appointed vice president and Global Head for the Infectious Disease & Vaccines Therapeutic Group at ICON Clinical Research.
Read More »
July 14, 2010
Aestus Therapeutics and Eisai have entered into a collaboration to research and develop therapeutics for the treatment of psychiatric disorders.
Read More »
July 12, 2010
Penn Pharma and Xcelience, LLC have entered into a joint venture agreement to provide Capsugel’s Xcelodose precision powder micro-dosing system technology on a global basis.
Read More »
July 12, 2010
MRC Technology has entered into an agreement with Genentech, a wholly owned member of the Roche Group, for an exclusive license to a series of small molecule drug candidates for the potential treatment of neurological disease.
Read More »
July 9, 2010
Adimab, Inc. has entered into a research collaboration in which it will use its discovery platform to identify fully human antibodies against two targets selected by Novartis.
Read More »
July 8, 2010
AAIPharma Services and CritiTech, Inc. have entered a strategic alliance to expand the reach of the CritiTech's technology.
Read More »
556 - 570 of 1091 results
